On Friday, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) opened higher 9.97% from the last session, before settling in for the closing price of $13.64. Price fluctuations for TNXP have ranged from $6.76 to $1193.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 95.88% at the time writing. With a float of $5.59 million, this company’s outstanding shares have now reached $155.63 million.
Let’s look at the performance matrix of the company that is accounted for 103 employees. In terms of profitability, gross margin is 7.54%, operating margin of -731.49%, and the pretax margin is -1197.86%.
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.00%, while institutional ownership is 2.86%.
Tonix Pharmaceuticals Holding Corp (TNXP) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -640 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 95.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 78.59% during the next five years compared to 79.31% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Check out the current performance indicators for Tonix Pharmaceuticals Holding Corp (TNXP). In the past quarter, the stock posted a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.56, a number that is poised to hit -18.50 in the next quarter and is forecasted to reach -62.00 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.54 million. As of the previous 9 days, the stock’s Stochastic %D was 61.13%. Additionally, its Average True Range was 3.02.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 6.69%, which indicates a significant decrease from 69.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 198.42% in the past 14 days, which was lower than the 258.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.02, while its 200-day Moving Average is $54.87. Nevertheless, the first resistance level for the watch stands at $15.95 in the near term. At $16.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.12. If the price goes on to break the first support level at $13.78, it is likely to go to the next support level at $12.55. Assuming the price breaks the second support level, the third support level stands at $11.61.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
There are currently 1,869K shares outstanding in the company with a market cap of 83.86 million. Presently, the company’s annual sales total 7,770 K according to its annual income of -116,660 K. Last quarter, the company’s sales amounted to 2,820 K and its income totaled -14,210 K.
